Abbvie Statistics, Revenue Totals, Facts & News (2022)
Last Updated on: August 2nd, 2022
Here are a few of the most interesting Abbvie statistics and facts I was able to dig up including revenue totals and employee counts. As always, be sure to check back in the future as I will be updating this post as new and updated stats become available.
Abbvie Facts
Here is pretty much everything you ever wanted to know about Abbvie.
- Abbvie Website: Official Website
- Year Abbvie was Founded: 2013
- Abbvie Headquarters: Chicago, IL
- Abbvie Founder(s): Spinoff from Abbott Labs
- Current Abbvie Chief Executive: Richard Gonzalez
- Abbvie Subsidiaries / Brands: Allergan
What is Abbvie?
AbbVieâs mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on peopleâs lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, womenâs health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. (source)
Abbvie Revenue Totals
Abbvie annual revenue:
- 2021: $56.197 billion
- 2020: $45.804 billion
- 2019: $33.266 billion
- 2018: $32.753 billion
- 2017:Â $28.216 billion
- 2016:Â $25.638 billion
- 2015:Â $22.859 billion
- 2014:Â $19.960 billion
- 2013:Â $18.790 billion
Abbvie annual net earnings:
- 2021: $11.549 billion
- 2020: $4.622 billion
- 2019: $7.882 billion
- 2018: $5.687 billion
- 2017: $5.309 billion
- 2016: $5.953 billion
- 2015: $5.144 billion
- 2014:Â $1.774 billion
Additional Abbvie Statistics
Number of countries where Abbvie products are sold:
Last updated 9/12/18
Number of Abbvie manufacturing centers:
Last updated 9/12/18
Number of Abbvie R&D centers:
Last updated 9/12/18
Number of Abbvie patients:
Last updated 9/12/18
Percentage of Abbvie’s workforce that are women:
Last updated 9/12/18
Recent Abbvie News
Here are some recent Abbvie news articles. We update company news daily, as it breaks, so be sure to check back often for the latest.
- AbbVie Completes Acquisition of Syndesi Therapeutics, for Up To USD1 Billion, 03/13/2022
- AbbVie Announces U.S. FDA Granted Breakthrough Therapy Designation (BTD) to Telisotuzumab Vedotin (Teliso-V) for Previously Treated Non-Small Cell Lung Cancer, 01/04/2022
Please note that some of these numbers are easier to find than others. A few of these Abbvie statistics come from their own reports, but some are based on news reports and not official company tallies. No information contained on DMR should be relied upon to make investment decisions. Basically, this is the best I can find and I donât guarantee anything to be 100%.
Related Categories:
Related Tags: